Violet Therapeutics is a pre-clinical stage company leveraging a first-in-class platforms to identify, map and mine cell-to-cell communication at scale. Violet’s drug discovery programs are focused on CNS diseases enabled by the novel targets elucidated by their platforms. Violet was co-founded in 2021 by Mass General Brigham Ventures and scientists from Brigham & Women’s Hospital.
Company Details
- Employees
- 9
- Address
- Cambridge, Ma 02139, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.violettx.com
- HQ
- Cambridge, MA
Violet Therapeutics Questions
Violet Therapeutics's website is http://www.violettx.com
Violet Therapeutics's LinkedIn profile is https://www.linkedin.com/company/violet-therapeutics
Violet Therapeutics has
9 employees.
View email and phone details for 9
employees at Violet Therapeutics.
Violet Therapeutics's industry is
Biotechnology Research
Violet Therapeutics's top competitors are
Hovana,
Zenon Biotech,
Eledon Pharmaceuticals, Inc.,
Nido Biosciences,
Mediar Therapeutics,
Mass General Brigham Ventures,
Quotient Therapeutics,
Seismic Therapeutic,
Morphic Therapeutic,
Sonata Therapeutics.
Violet Therapeutics's categories are Biotechnology Research
